Topical JAK Inhibitor Active in Itchy Prurigo Nodularis

(MedPage Today) — ORLANDO — More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting topical ruxolitinib (Opzelura), according to a study reported here.
After 12 weeks of treatment…